IP Library Granted Patent US 6,953,586
Granted Patent B1
US 6,953,586 · App. 09/589,730 · Granted Oct 11, 2005

Growth promoting pharmaceutical implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,953,586
App. No.
09/589,730
Granted
Oct 11, 2005
Kind
B1
Abstract

A combination growth promoting pharmaceutical pellet system which delivers doses of both a growth stimulating pharmaceutical agent and a supplemental agent that enhances the growth produced by the growth stimulating agent as part of a single procedure wherein the doses have a synergistic or augmentative effect on physiological growth and weight gain. The system includes an implanter apparatus for subcutaneously implanting pellets in an animal through the bore of a hypodermic needle which is operably coupled to a pellet magazine, and a plurality of pellets sized to be implanted through the needle and positioned in the magazine for selective alignment of a pellet with the needle. The pellets include at least one growth stimulating pharmaceutical agent dose pellet. The implant also includes a supplemental agent dose selected from the group of parasiticides, antibiotics, estrus suppressing compositions, somatotropins, gonadotropins and mixtures thereof. The various agents preferably include both immediate release and time delayed release components.

Claims (14)

1. A bio-absorbable and bio-compatible implant for placement under the skin of an animal comprising:

at least one discrete, solid pellet having a growth promoting agent comprising from about 20–200 mg trenbolone acetate;

at least one discrete, solid pellet having a supplemental agent comprising from about 10–100 mg melengesterol acetate;

wherein said agents combine to promote growth in an animal.

2. The implant according to claim 1 wherein said growth promoting agent further comprises from about 5–50 mg estradiol benzoate.

3. The implant according to claim 1 wherein said growth promoting agent further comprises from about 5–50 mg estradiol.

4. A bio-absorbable and bio-compatible implant for placement under the skin of an animal comprising:

at least one discrete, solid pellet having a growth promoting agent comprising from about 5–50 mg estradiol benzoate;

at least one discrete, solid pellet having a supplemental agent comprising from about 10–100 mg melengesterol acetate;

wherein said agents combine to promote growth in an animal.

5. A bio-absorbable and bio-compatible implant for placement under the skin of an animal comprising:

at least one discrete, solid pellet having a growth promoting agent comprising from about 5–50 mg estradiol;

at least one discrete, solid pellet having a supplemental agent comprising from about 10–100 mg melengesterol acetate;

wherein said agents combine to promote growth in an animal.

Assignments (5)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON AUGUST 3, 2020, AT REEL/FRAME 053388/0967 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0021 →
SECURITY INTEREST Recorded Aug 3, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 053388/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ELI LILLY AND COMPANY
To: ELANCO US INC.
Reel/Frame 044701/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2012
From: IVY ANIMAL HEALTH, INC.
To: ELI LILLY AND COMPANY
Reel/Frame 028693/0112 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2012
From: BMO HARRIS BANK N.A.
To: IVY ANIMAL HEALTH, INC.
Reel/Frame 028108/0955 →